J.P. Morgan Asset Management announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team will invest in both early and growth stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas...

Related Keywords

New York , United States , Dana Farber Cancer Institute , Massachusetts , Cornell University , Harvard University , Columbia University , American , Stephen Oesterle , Laurie Glimcher , Frederic Moll , George Gatch , Anya Schiess , Gaurav Gupta , Brian Carlin , Robert Stockman , Robert Bob Stockman , Stephen Squinto , Laurieh Glimcher , Johns Hopkins University , Distinction At Harvard University , Tulane University , Stanford University School Of Medicine , Columbia University Medical Center , Provost For Medical Affairs Of Cornell University , Massachusetts Competitive Partnership , Massachusetts Mutual Life Insurance Company , Wharton School , Harvard Medical School Board Of Fellows , University Of Chicago , Pharmaceuticals Products Group , Vertex Pharmaceuticals , Critikon Company , Regeneron Pharmaceuticals Inc , Alexion Pharmaceuticals , Life Sciences Private Capital , Harvard Medical School , American Academy Of Arts , Alexion Pharmaceuticals Inc , American Association Of Immunologists , Yale Medical School , Global Healthcare Exchange , Casana Health , Cardinal Health , Squinto As Co , University Of Pennsylvania , Auris Health Inc , Medtronic , Jj Medical Devices Companies , Member Of The National Academy Sciences , Business Development , Dartmouth Tuck School Of Business , Strategy Committee , Loyola University Of Chicago , American Philosophical Society , National Academy Of Medicine , University Of Washington , Regeneron Pharmaceuticals , Partner Of Life Sciences Private Capital , Alexion Global Head Of Research , Medtronic Executive Committee , Stanford Business School , Princeton University , Waters Corporation , University Of California At Berkeley , Dana Farber Harvard Cancer Center , Glaxosmithkline Pharmaceutical Corporation , Abbott Laboratories , Board Of Directors Analog Devices Inc , Johnson , A Company Orthodontics Inc , Asset Management , Life Sciences Private , Genetic Medicine , Neurodegenerative Disease , Rare Diseases , Metabolic Diseases , Private Capital , Chief Investment Officer , Managing Partner , Orbimed Advisors , Co Managing Partners , Ascendant Biocapital , General Partner , Chief Executive Officer , Strategic Advisors , Dana Farber Cancer , Executive Chairman , Chief Development Officer , Former Medtronic , Former Chairman , Executive Partner , Executive Vice President , Chief Global Operations , Global Head , Loyola University , Columbia University Medical , Stanford University School , Daisy Soros Fellow , Johns Hopkins , Healthy Ventures , Harvard Cancer Center , Susan Smith Professor , Harvard Medical , Suzanne Weiss Dean , Weill Cornell Medicine , Medical Affairs , National Academy , American Academy , American Association , Bristol Myers Squibb Pharmaceutical Corporation , Analog Devices , Clarus Ventures , Chief Operating Officer , Chief Scientific Officer , Odyssey Therapeutics , Revolution Healthcare , Harvard Medical School Board , Auris Health , Intuitive Surgical , Hansen Medical , Origin Medsystems , Stanford Business , Senior Vice President , Yale Medical , Tuck School ,